In conclusion, the above results indicate that the expression of SLC1A5 is closely related to the activation of the tumor immune microenvironment and the malignant phenotype of various cancers, which provides new clues for us to further explore the role of SLC1A5 in tumor progression. This evidence concerns the gene SLC1A5 and neoplasm.